EXACT Therapeutics
Caspar Foghsgaard is the Chief Business Officer at EXACT Therapeutics and Sr. VP Commercial and Business Development at Scipio Bioscience. Caspar is also the Chairman of the Board of Directors at Stella Nova Copenhagen A/S and a former member of the Board of Directors at Labflex A/S. Foghsgaard has experience in business development, acquisitions, and board memberships across various companies in the pharmaceutical and spirits industries. Additionally, Caspar holds a Bsc (Honours) in Chemistry with Biological Chemistry and a MSc in Management.
EXACT Therapeutics
1 followers
EXACT Therapeutics is a clinical stage Norwegian biotech company developing a technology platform for targeted therapeutic enhancement – Acoustic Cluster Therapy (ACT®). ACT®sonoporation is a unique approach to ultrasound-mediated, targeted drug enhancement – with the potential to significantly amplify the clinical utility of a wide range of therapeutic agents across a multitude of indications including within oncology (chemotherapy, immunotherapy), infectious diseases, and neurological conditions.